<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.0//EN" "ep-patent-document-v1-0.dtd">
<ep-patent-document id="EP01983349B8W1" file="01983349.xml" lang="en" country="EP" doc-number="1333858" kind="B8" correction-code="W1" date-publ="20060614" status="c" dtd-version="ep-patent-document-v1-0">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIE......FI....CY..TR............................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>DIM360 (Ver 1.5  21 Nov 2005) -  2999001/0</B007EP></eptags></B000><B100><B110>1333858</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20060614</date></B140><B150><B151>W1</B151><B152><date>00000000</date></B152><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>01983349.0</B210><B220><date>20011031</date></B220><B240><B241><date>20030604</date></B241><B242><date>20040609</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>246075 P</B310><B320><date>20001107</date></B320><B330><ctry>US</ctry></B330><B310>307159 P</B310><B320><date>20010724</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20060614</date><bnum>200624</bnum></B405><B430><date>20030813</date><bnum>200333</bnum></B430><B450><date>20060208</date><bnum>200606</bnum></B450><B452EP><date>20050722</date></B452EP><B480><date>20060614</date><bnum>200624</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  39/39        20060101AFI20020517BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  39/00        20060101ALI20020517BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61K  39/29        20060101ALI20020517BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>A61K   9/00        20060101ALI20020517BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>A61K   9/127       20060101ALI20020517BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>A61P  15/00        20060101ALI20020517BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>IMPFSTOFFE MIT ERHÖHTER IMMUNANTWORT UND VERFAHREN ZUR DEREN HERSTELLUNG</B542><B541>en</B541><B542>VACCINES WITH ENHANCED IMMUNE RESPONSE AND METHODS FOR THEIR PREPARATION</B542><B541>fr</B541><B542>VACCINS A REPONSE IMMUNITAIRE ACCRUE ET LEURS PROCEDES DE PREPARATION</B542></B540><B560><B561><text>WO-A-00/37100</text></B561><B561><text>WO-A-92/00081</text></B561><B561><text>US-A- 5 422 109</text></B561><B561><text>US-A- 5 736 141</text></B561><B562><text>H. NASH ET AL.: "Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). II. Use of compounds of the muramyl dipeptide (MDP) family as adjuvants." JOURNAL OF REPRODUCTIVE IMMUNOLOGY, vol. 7, no. 2, 1985, pages 151-162, XP001053240 Amsterdam, The Netherlands</text></B562><B562><text>A. HILBERT ET AL.: "Biodegradable microspheres containing influenza A vaccine: immune response in mice." VACCINE, vol. 17, no. 9-10, March 1999 (1999-03), pages 1065-1073, XP004158227 Guildford, GB</text></B562><B562><text>R. GUPTA ET AL.: "Adjuvants for human vaccines - current status, problems and future prospects." VACCINE, vol. 13, no. 14, October 1995 (1995-10), pages 1263-1276, XP004057427 Guildford, GB</text></B562><B562><text>D. PYE ET AL.: "Selection of an adjuvant for vaccination with the malaria antigen, MSA-2." VACCINE, vol. 15, no. 9, June 1987 (1987-06), pages 1017-1023, XP004115370 Guildford, GB</text></B562><B562><text>ALLISON A. METHODS vol. 19, no. 1, 1999, pages 87 - 93</text></B562><B562><text>LAWRENCE G.W. ET AL VACCINE vol. 15, no. 2, 1997, pages 176 - 178</text></B562><B562><text>STONE H.D. AVIAN DIS. vol. 37, no. 2, 1993, pages 399 - 405</text></B562><B562><text>YARKONI E. ET AL CANCER RES. vol. 39, no. 5, 1979, pages 1518 - 1520</text></B562><B562><text>EGHAFONA N.O. VACCINE vol. 14, no. 17-18, 1996, pages 1518 - 1520</text></B562><B562><text>CHANG J.C.C. ET AL ADVANCED DRUG DELIVERY REVIEWS vol. 32, 1998, pages 173 - 186</text></B562></B560></B500><B700><B720><B721><snm>BROWN, Robert, George</snm><adr><str>18 Swanton Drive</str><city>Dartmouth, Nova Scotia B2W 2C4</city><ctry>CA</ctry></adr></B721><B721><snm>POHAJDAK, Bill</snm><adr><str>83 Shrewsbury Road</str><city>Dartmouth, Nova Scotia B2V 2C4</city><ctry>CA</ctry></adr></B721><B721><snm>KIMMINS, Warwick, Charles</snm><adr><str>5865 Balmoral Road</str><city>Halifax, Nova Scotia B3H 1A5</city><ctry>CA</ctry></adr></B721></B720><B730><B731><snm>ImmunoVaccine Technologies Inc.</snm><iid>04519530</iid><irf>SCB/63344/000</irf><adr><str>Suite 303, 
1819 Granville Street</str><city>Halifax,
Nova Scotia B3J 3R1</city><ctry>CA</ctry></adr></B731></B730><B740><B741><snm>Baldock, Sharon Claire</snm><sfx>et al</sfx><iid>00073341</iid><adr><str>BOULT WADE TENNANT, 
Verulam Gardens 
70 Gray's Inn Road</str><city>London WC1X 8BT</city><ctry>GB</ctry></adr></B741></B740></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>IE</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LU</ctry><ctry>MC</ctry><ctry>NL</ctry><ctry>PT</ctry><ctry>SE</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>CA2001001530</anum></dnum><date>20011031</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2002038175</pnum></dnum><date>20020516</date><bnum>200220</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
